Fibroblast-tumor Cell Signaling Limits HER2 Kinase Therapy Response via Activation of MTOR and Antiapoptotic Pathways
Publication information:
Zervantonakis I, Poskus M, Scott A, Selfors L, Lin J, Dillon D, Pathania, Sorger P, Mills G, Brugge J. Fibroblast-tumor Cell Signaling Limits HER2 Kinase Therapy Response via Activation of MTOR and Antiapoptotic Pathways.
Proc Natl Acad Sci USA. 2020;117(28):16500–16508.